Scandinavian ChemoTech AB
Anders Johnsson is the Business Unit Director at Scandinavian ChemoTech in Lund, Sweden. Mr Johnsson was instrumental in the development of the early electroporation devices and also pioneered the introduction of the first generation of electrochemotherapy to the clinics in Scandinavia. Today he is working with the second generation of electrochemotherapy, called Dynamic-ElectroEnhanced Chemotherapy which is targeted for both human and veterinary use.
Dynamic-ElectroEnhanced Chemotherapy brings relief to palliative patients with a large tumour burden
Why larger tumours (exceeding 3 cm in diameter and 1.5 cm in depth) could not previously be treated with electrochemotherapy. Introducing a new protocol called Dynamic-ElectroEnhanced Chemotherapy and presenting its clinical data.
EVEN MORE SEMINARS
Prof Ingunn Holen Department of Oncology and Metabolism, University of Sheffield, UK
Tumour cell dormancy and breast cancer relapse
Professor Jayant Vaidya University College London
Targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer
Dr. Catherine Zollman Penny Brohn UK
Integrative oncology: supporting whole person resilience and improving cancer outcomes
Neil Oakley Sheffield Teaching Hospitals NHS Trust
Robotic Radical Prostatectomy for Prostate cancer aiming for Trifecta 2020
Chris Carrigan Bowel Cancer Intelligence UK
Patient Engagement in the uses of Patient Data